Extended cycle hormonal contraception in adolescents

Current Opinion in Obstetrics and Gynecology

Volumn 17, Issue 5, 2005, Pages 461-465

  Sucato, Gina S ^a,b   Gerschultz, Kelly L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Adolescent Medicine G437   (United States)

Author keywords

Adolescent; Extended cycle; Hormonal contraception

Indexed keywords

CONTRACEPTIVE AGENT; DESOGESTREL PLUS ETHINYLESTRADIOL; ESTRADIOL; ETHINYLESTRADIOL PLUS GESTODENE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; FOLLITROPIN; LUTEINIZING HORMONE; PLACEBO;

ADOLESCENCE; BONE DENSITY; BREAKTHROUGH BLEEDING; CANCER; CLINICAL TRIAL; DRUG EFFICACY; DRUG PREFERENCE; DRUG SAFETY; DRUG TOLERABILITY; ENDOMETRIUM ATROPHY; ENDOMETRIUM BIOPSY; FEMALE FERTILITY; FIBRINOLYSIS; HEALTH CARE PERSONNEL; HORMONAL CONTRACEPTION; HORMONE BLOOD LEVEL; HORMONE METABOLISM; HUMAN; MENSTRUAL CYCLE; OVARY FOLLICLE; OVARY FUNCTION; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; THROMBOSIS;

EID: 25444504307     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gco.0000178436.33998.8f     Document Type: Review

References (33)

1. Davis AR, Westhoff CL. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J Pediatr Adolesc Gynecol 2001; 14 (1):3-8.
2. Sulak PJ, Scow RD, Preece C, et al. Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 2000; 95 (2):261-266.
3. Sulak PJ, Cressman BE, Waldrop E, et al. Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms. Obstet Gynecol 1997; 89 (2):179-183.
4. Sillem M, Schneidereit R, Heithecker R, Mueck AO. Use of an oral contraceptive containing drospirenone in an extended regimen. Eur J Contracept Reprod Health Care 2003; 8 (3):162-169.
5. Vercellini P, Frontino G, De Giorgi O, et al. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil Steril 2003; 80 (3):560-563.
6. Aubeny E, Buhler M, Colau JC, et al. The Coraliance study: non-compliant behavior - results after a 6-month follow-up of patients on oral contraceptives. Eur J Contracept Reprod Health Care 2004; 9 (4):267-277.
7. Schlaff WD, Lynch AM, Hughes HD, et al. Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression. Am J Obstet Gynecol 2004; 190 (4):943-951. This study comparing follicular suppression with three different contraceptive regimens supports the concept of shortening or eliminating the hormone-free interval to improve contraceptive efficacy.
8. Spona J, Elstein M, Feichtinger W, et al. Shorter pill-free interval in combined oral contraceptives decreases follicular development. Contraception 1996; 54 (2):71-77.
9. Anderson FD, Hait H. A multicenter, randomized study of an extended cycle oral contraceptive. Contraception 2003; 68 (2):89-96.
10. Miller L, Hughes JP. Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial. Obstet Gynecol 2003; 101 (4):653-661.
11. Kwiecien M, Edelman A, Nichols MD, Jensen JT. Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial. Contraception 2003; 67 (1):9-13.
12. Wiegratz I, Hommel HH, Zimmermann T, Kuhl H. Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives. Contraception 2004; 69 (1):37-42. This multi-part study investigated the menstrual preferences of German women and adolescents, the attitudes of German gynecologists towards suppression of withdrawal bleeding, and the experiences of women using 6 months of continuous cycling. The results are comparable to findings in the United States.
13. Machado RB, Fabrini P, Cruz AM, et al. Clinical and metabolic aspects of the continuous use of a contraceptive association of ethinyl estradiol (30 microg) and gestodene (75 microg). Contraception 2004; 70 (5):365-370. This non-comparative study of 6 months of continuous cycling found metabolic changes similar to those expected with traditional use of oral contraceptives.
14. Cachrimanidou AC, Hellberg D, Nilsson S, et al. Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive. Contraception 1994; 50 (2): 153-165.
15. Ferreira AC, Montes MB, Franceschini SA, Toloi MR. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women. Int J Fertil Womens Med 2001; 46 (5):265-270.
16. Anderson FD, Hait H, Hsiu J, et al. Endometrial microstructure after long-term use of a 91-day extended-cycle oral contraceptive regimen. Contraception 2005; 71 (1):55-59. This is the largest and longest study of endometrial biopsies in women using extended cycles. It demonstrated the expected endometrial findings, including an absence of abnormalities in any samples.
17. Putter W, Knight C, Vizzard J, et al. Women's attitudes to withdrawal bleeding and their knowledge and beliefs about the oral contraceptive pill. Med J Aust 1988; 149 (8):417-419.
18. Hitchcock CL, Prior JC. Evidence about extending the duration of oral contraceptive use to suppress menstruation. Womens Health Issues 2004; 14 (6):201-211.
19. van Hooff MH, Voorhorst FJ, Kaptein MB, et al. Endocrine features of polycystic ovary syndrome in a random population sample of 14-16 year old adolescents. Hum Reprod 1999; 14 (9):2223-2229.
20. Wiegratz I, Kuhl H. Long-cycle treatment with oral contraceptives. Drugs 2004; 64 (21):2447-2462.
21. Cromer BA, Stager M, Bonny A, et al. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J Adolesc Health 2004; 35 (6):434-441.
22. Andrist LC, Arias RD, Nucatola D, et al. Women's and providers' attitudes toward menstrual suppression with extended use of oral contraceptives. Contraception 2004; 70 (5):359-363.
23. ACOG news release. Gallup survey reveals women ob-gyns benefit from 'insider knowledge' [electronic citation]. Gallup Organization; 15 May 2005.
24. Gerschultz K, Sucato GS, Russell T, Gold MA. Physician views on extended cycling of combined hormonal contraceptives in adolescents [abstract]. J Adolesc Health 2005; 36 (2): 146-147.
25. Association of Reproductive Health Professionals and National Association of Nurse Practitioners in Women's Health [electronic citation]. Annual meeting registrant survey. August-September 2002.
26. Association of Reproductive Health Professionals. Extended regimen oral contraceptives [electronic citation]. Harris Poll; 14-17 June 2002.
27. den Tonkelaar I, Oddens BJ. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use. Contraception 1999; 59 (6):357-362.
28. Glasier AF, Smith KB, van der Spuy ZM, et al. Amenorrhea associated with contraception: an international study on acceptability. Contraception 2003; 67 (1):1-8.
29. Andrist LC, Hoyt A, Weinstein D, McGibbon C. The need to bleed: women's attitudes and beliefs about menstrual suppression. J Am Acad Nurse Pract 2004; 16 (1):31-37.
30. Johnston-Robledo I, Ball M, Lauta K, Zekoll A. To bleed or not to bleed: young women's attitudes toward menstrual suppression. Women Health 2003; 38 (3):59-75.
31. Hamerlynck JV, Vollebregt JA, Doornebos CM, Muntendam P. Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives. Contraception 1987; 35 (3): 199-205.
32. Cachrimanidou AC, Hellberg D, Nilsson S, et al. Long-interval treatment regimen with a desogestrel-containing oral contraceptive. Contraception 1993; 48 (3):205-216.
33. Sulak PJ, Carl J, Gopalakrishnan I, et al. Outcomes of extended oral contraceptive regimens with a shortened hormone-free interval to manage breakthrough bleeding. Contraception 2004; 70 (4):281-287. This retrospective review documents the experiences of a large series of women using an unscheduled extended cycling regimen with a shortened hormone-free interval.